The transit of dosage forms through the small intestine

International Journal of Pharmaceutics

Volumn 395, Issue 1-2, 2010, Pages 9-16

  Yuen, Kah Hay ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Food; Gamma scintigraphy; Intestinal transit; Pharmaceutical excipients; Small intestine

Indexed keywords

AMPICILLIN; COCONUT OIL; EXCIPIENT; LACTULOSE; MACROGOL 400; MANNITOL; OLEIC ACID; PHENAZONE; PYROPHOSPHATE; RANITIDINE; WATER; XYLITOL; DRUG DOSAGE FORM;

DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG FORMULATION; FOOD; FOOD INTAKE; GAMMA SCINTIGRAPHY; HUMAN; IMAGE PROCESSING; INTESTINE TRANSIT TIME; LIQUID; PRIORITY JOURNAL; RELIABILITY; REVIEW; SMALL INTESTINE; SOLID STATE; TELEMETRY; TIME; DRUG EFFECTS; EATING; GASTROINTESTINAL TRANSIT; INTESTINE ABSORPTION; MEDICINAL CHEMISTRY; METHODOLOGY; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PHYSIOLOGY; REPRODUCIBILITY; SCINTISCANNING;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; DRUG COMPOUNDING; EATING; EXCIPIENTS; GASTROINTESTINAL TRANSIT; HUMANS; INTESTINAL ABSORPTION; INTESTINE, SMALL; PARTICLE SIZE; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 77954309697     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.04.045     Document Type: Review

References (68)

1. Adkin D.A., Davis S.S., Sparrow R.A., Huckle P.D., Phillips A.J., Wilding I.R. The effects of pharmaceutical excipients on small intestinal transit. Br. J. Clin. Pharmacol. 1995, 39:381-387.
2. Adkin D.A., Davis S.S., Sparrow R.A., Huckle P.D., Phillips A.J., Wilding I.R. The effect of different concentrations of mannitol in solution on small intestinal transit-implications for drug absorption. Pharm. Res. 1995, 12:393-396.
3. Alpsten M., Enkeved G., Sölvell L. A profile scanning method of studying the release properties of different types of tablets in man. Acta Pharm. Suec. 1976, 13:107-122.
4. Avill R., Mangnall Y.F., Bird N.C., Brown B.H., Barber D.C., Seagar A.D., Johnson A.G., Read N.W. Applied potential tomography. A new noninvasive technique for measuring gastric emptying. Gastroenterology 1987, 92:1019-1026.
5. Basit A.W., Newton J.M., Short M.D., Waddington W.A., Ell P.J., Lacey L.F. The effect of polyethylene glycol 400 on gastrointestinal transit: implications for the formulation of poorly-water soluble drugs. Pharm. Res. 2001, 18:1146-1150.
6. Basit A.W., Podczeck F., Newton J.M., Waddington W.A., Ell P.J., Lacey L.F. Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine. Pharm. Res. 2002, 19:1368-1374.
7. Billa N., Yuen K.H., Khader M.A.A., Omar A. Gamma-scintigraphic study of the gastrointestinal transit in vivo dissolution of a controlled release diclofenac sodium formulation in xanthan gum matrices. Int. J. Pharm. 2000, 201:109-120.
8. Cammack J., Read N.W., Cann P.A., Greenwood B., Holgate A.M. Effect of prolonged exercise on the passage of a solid meal through the stomach and small intestine. Gut 1982, 23:957-961.
9. Catnach S.M., Fairclough P.D. Erythromycin and the gut. Gut 1992, 33:397-401.
10. Casey D.L., Beihn R.M., Digenis G.A., Shambu M.B. Method for monitoring hard gelatin capsule disintegration times in humans using external scintigraphy. J. Pharm. Sci. 1976, 65:1412-1413.
11. Christensen F.N., Davis S.S., Hardy J.G., Taylor M.J., Whalley D.R., Wilson C.G. The use of gamma scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations. J. Pharm. Pharmacol. 1985, 37:91-95.
12. Clarke G.M., Newton J.M., Short M.B. Gastrointestinal transit of pellets of differing size and density. Int. J. Pharm. 1993, 100:81-92.
13. Clarke G.M., Newton J.M., Short M.B. Comparative gastrointestinal transit of pellets systems of varying density. Int. J. Pharm. 1995, 114:1-11.
14. Clements J.A., Heading R.C., Nimmo W.S., Prescott L.F. Kinetics of acetaminophen absorption and gastric emptying in man. Clin. Pharmacol. Ther. 1978, 24:420-431.
15. Coupe A.J., Davis S.S., Wilding I.R. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm. Res. 1991, 8:360-364.
16. Daly P.B., Davis S.S., Frier M., Hardy J.G., Kennerley J.W., Wilson C.G. Scintigraphic assessment of the in vivo dissolution rate of sustained release tablet. Int. J. Pharm. 1982, 10:17-24.
17. Davenport H.W. Physiology of the digestive tract 1977, Year Book Medical Publishers Incorporated, Chicago, 205-215. 4th edition.
18. Davis S.S., Hardy J.G., Fara J.W. Transit of pharmaceutical dosage forms through the small intestine. Gut 1986, 27:886-892.
19. Davis S.S., Hardy J.G., Newman S.P., Wilding I.R. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Eur. J. Nucl. Med. 1992, 19:971-986.
20. Davis S.S., Hardy J.G., Taylor M.J., Whalley D.R., Wilson C.G. The effect of food on the gastrointestinal transit of pellets and an osmotic device (Osmet). Int. J. Pharm. 1984, 21:331-340.
21. Davis S.S., Parr G.D., Feely L.C., Leslie S.T., Malkowska S., Lockwood G.F. The gastrointestinal transit investigation of a controlled release aminophylline formulation. Int. J. Pharm. 1989, 49:183-188.
22. Devereux J.E., Newton J.M., Short M.B. The influence of density on the gastrointestinal transit of pellets. J. Pharm. Pharmacol. 1990, 42:500-501.
23. Digenis G.A., Sandefer E.P., Parr A.F., Beihn R., McClain C., Scheinthal B.M., Ghebre-Sellassie I., Iyer U., Nesbitt R.U., Randinitis E. Gastrointestinal behaviour of orally administered radiolabeled erythromycin pellets in man as determined by gamma scintigraphy. J. Clin. Pharmacol. 1990, 30:621-631.
24. Dobson C.L., Davis S.S., Chauhan S., Sparrow R.A., Wilding I.R. The effect of oleic acid on the human ileal brake and its implications for small intestinal transit of tablet formulations. Pharm. Res. 1999, 16:92-96.
25. Evans D.F., Pye G., Clark A.G., Dyson T.J., Hardcastle J.D. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988, 29:1035-1041.
26. Fadda H.M., McConnell E.L., Short M.D., Basit A.W. Meal-induced acceleration of tablet transit through the human small intestine. Pharm. Res. 2009, 26:356-360.
27. Fallingborg J., Christensen L.A., Ingeman-Nielsen M., Jacobsen B.A., Abildgaard K., Rasmussen H.H. pH-profile and regional transit times of the normal gut measured by a radiotelemetry device. Aliment Pharmacol. Ther. 1989, 3:605-613.
28. Fallingborg J., Christensen L.A., Ingeman-Nielsen M., Jacobsen B.A., Abildgaard K., Rasmussen H.H., Rasmussen S.N. Measurement of gastrointestinal pH and regional transit times in normal children. J. Pediatr. Gastroenterol. Nutr. 1990, 11:211-214.
29. Godbillon J., Evard D., Vidon N., Dural M., Schoeller J.P., Bernier J.J., Hirtz J. Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Br. J. Clin. Pharmacol. 1985, 19:113s-118s.
30. Goodman K., Hodges L.A., Band J., Stevens H.N.E., Weitschies W., Wilson C.G. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy. Eur. J. Pharm. Biopharm. 2010, 74:84-92.
31. Hardy J.G., Wilson C.G., Wood E. Drug delivery to the proximal colon. J. Pharm. Pharmacol. 1985, 37:874-877.
32. Hardy J.G., Healey J.N.C., Lee S.W., Reynolds J.R. Gastrointestinal transit of an enteric-coated delayed-release 5-aminosalicylic acid tablet. Aliment Pharmacol. Ther. 1987, 1:209-216.
33. Heading R.C., Nimmo J., Prescott L.F., Tothill P. The dependence of paracetamol absorption on the rate of gastric emptying. Br. J. Pharmacol. 1973, 47:415-421.
34. Hirtz J. The absorption window: fact or fiction?. Pharm. Int. 1984, 5:175-178.
35. Hofmann A.F., Pressman J.H., Code C.F., Witztum K.F. Controlled entry of orally administered drugs: physiological considerations. Drug Dev. Ind. Pharm. 1983, 9:1077-1109.
36. Kennedy M., Chimwah P., Wade D.M. A pharmalogical method of measuring mouth caecal transit time in man. Br. J. Clin. Pharmacol. 1979, 8:372-373.
37. Kenyon C.J., Hooper G., Tierney D., Butler J., Devane J., Wilding I.R. The effect of food on the gastrointestinal transit and systemic absorption of naproxen from a novel sustained release formulation. J. Control. Release 1995, 34:31-36.
38. Kerlin P., Zinsmeister A., Phillips S. Relationship of motility to flow of contents in the human small intestine. Gastroenterology 1982, 82:701-706.
39. Koch K.M., Parr A.F., Tomlinson J.J., Sandefer E.P., Digenis G.A., Donn K.H., Powell J.R. Effect of sodium acid pyrophosphate on ranitidine bioavailability and gastrointestinal transit time. Pharm. Res. 1993, 10:1027-1030.
40. Koch-Weser J., Schechter P.J. Slow-release preparations in clinical perspective. Drug Absorption 1981, 217-227. MTP Press, Lancaster. L.F. Prescott, W.S. Nimmo (Eds.).
41. Maublant J.C., Sournac M., Aiache J.M., Veyre A. Dissolution rate and transit times of technetium-99m DTPA-labeled tablets. J. Nucl. Med. 1987, 28:1199-1203.
42. Maublant J.C., Hassine H., Sournac M., Dapogny M., Veyre M., Aiache J.M., Goutay E. Ultrasonic visualization of tablets in the gastrointestinal tract. J. Nucl. Med. 1988, 29:129.
43. Metcalf S.J., Phillips S.F., Zinsmeister A.R., MacCarty R.L., Beart R.W., Wolff B.G. Simplified assessment of segmental colonic transit. Gastroenterology 1987, 92:40-47.
44. Mouly S., Paine M.F. P-glycoprotein increases from proximal to distal regions of human small intestine. Pharm. Res. 2003, 20:11595-11599.
45. Mundy M.J., Wilson C.G., Hardy J.G. The effect of eating on transit through the small intestine. Nucl. Med. Commun. 1989, 10:45-50.
46. Peh K.K., Yuen K.H. Indirect gastrointestinal monitoring and absorption of theophylline. Int. J. Pharm. 1996, 139:95-103.
47. Podczeck F., Newton J.M., Yuen K.H. The description of the gastrointestinal transit of pellets assessed by gamma scintigraphy using statistical moments. Pharm. Res. 1995, 12:376-379.
48. Podczeck F., Course N.J., Newton J.M. Determination of the gastric emptying of solid dosage forms using gamma-scintigraphy: a problem of image timing and mathematical analysis. Eur. J. Nucl. Med. 1999, 26:373-378.
49. Podczeck F., Course N.J., Newton J.M., Short M.B. Gastrointestinal transit of model mini-tablet controlled release oral dosage forms in fasted human volunteers. J. Pharm. Pharmacol. 2007, 59:941-945.
50. Prokop E.K., Caride V.J., Marano A.R., et al. Scintigraphic determination of small intestinal transit time of water in man. J. Nucl. Med. 1984, 25:P97.
51. Read N.W., Cammack J., Edwards C., Holgate A.M., Cann P.A., Brown C. Is the transit time of a meal through the small intestine related to the rate at which it leaves the stomach?. Gut 1982, 23:824-828.
52. Read N.W., Al-Janabi M.N., Holgate A.M., Barber D.C., Edwards C.A. Simultaneous measurement of gastric emptying, small bowel residence and colonic filling of a solid meal by the use of the gamma camera. Gut 1986, 27:300-308.
53. Read N.W., Miles C.A., Fisher D., Holgate A.M., Kime N.D., Mitchell M.A., Reeve A.M., Roche T.B., Walker M. Transit of a meal through the stomach, small intestine, and colon in normal subjects and its role in the pathogenesis of diarrhea. Gastroenterology 1980, 79:1276-1282.
54. Salminen E.K., Salminen S.J., Porkka L., Kwasowski P., Marks V., Koivistoinen P.E. Xylitol vs glucose: effect on the rate of gastric emptying and motilin, insulin, and gastric inhibitory polypeptide release. Am. J. Clin. Nutr. 1989, 49:1228-1232.
55. Schiller C., Fröhlich P., Giessmann T., Siegmund W., Mönnikes§ H., Hosten N., Weitschies W. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol. Ther. 2005, 22:971-979.
56. Schulze J.D.R., Waddington W.A., Ell P.J., Parsons G.E., Coffin M.D., Basit A.W. Concentration-dependent effects of polyethylene glycol 400 on gastrointestinal transit and drug absorption. Pharm. Res. 2003, 20:1984-1988.
57. Schulze J.D.R., Peters E.E., Vickers A.W., Staton J.S., Coffin M.D., Parsons G.E., Basit A.W. Excipient effects on gastrointestinal transit and drug absorption in beagle dogs. Int. J. Pharm. 2005, 300:67-75.
58. Schulze J.D.R., Ashiru D.A.I., Khela M.K., Evans D.F., Patel R., Parsons G.E., Coffin M.D., Basit A.W. Impact of formulation excipients on human intestinal transit. J. Pharm. Pharmacol. 2006, 58:821-825.
59. Spiller R.C., Trotman I.F., Higgins B.F., Ghatei M.A., Grimble G.K., Lee Y.C., Bloom S.R., Misiewicz J.J., Silk D.B.A. The ileal brake inhibition of jejuna motility after ileal fat perfusion in man. Gut 1984, 25:365-374.
60. Staib A.H., Loew D., Harder S., Graul E.H., Pfab R. Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled drug delivery device. Eur. J. Clin. Pharmacol. 1986, 30:691-697.
61. Staniforth D.H. Comparison of orocaecal transit times assessed by the lactulose/breath hydrogen and the sulphasalazine/sulphapyridine methods. Gut 1989, 30:978-982.
62. Sutton J.A., Thompson S., Sobnack R. Measurement of gastric emptying rates by radioactive isotope scanning and epigastric impedance. Lancet 1985, 325:898-900.
63. Thummel K.E., Kunze K.L., Shen D.D. Enzyme catalysed processes of first-pass hepatic and intestinal drug extraction. Adv. Drug Deliv. Rev. 1997, 27:99-127.
64. Waller S.L. Differential measurement of small and large bowel transit times in constipation and diarrhoea: a new approach. Gut 1975, 16:372-378.
65. Weitschies W., Wedemeyer R.S., Kosch O., Fach K., Nagel S., Söderlind E., Trahms L., Abrahamsson B., Mönnikes H. Impact of the intragastric location of extended release tablets on food interactions. J. Control. Release 2005, 108:375-385.
66. Wilding I.R., Davis S.S., Steed K.P., Sparrow R.A., Westrup J., Hempenstall J.M. Gastrointestinal transit of a drug-resinate administered as an oral suspension. Int. J. Pharm. 1994, 101:263-268.
67. Yuen, K.H., 1991. Gastrointestinal transit and bioavailability of a novel sustained release theophylline formulation. Ph.D. Thesis. University of London.
68. Yuen K.H., Deshmukh A.A., Newton J.M., Short M., Melchor R. Gastrointestinal transit and absorption of theophylline from a multiparticulate controlled release formulation. Int. J. Pharm. 1993, 97:61-77.